G1 Therapeutics Total Liabilities (Quarterly) Analysis

G1 Therapeutics Inc (GTHX)

4.125 +0.36 (+9.42%) USD | NASDAQ | May 01, 16:00

4.125 0.00 (0.00%) After-Hours: 20:00

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	86.15M
September 30, 2023	90.08M
June 30, 2023	90.34M
March 31, 2023	116.97M
December 31, 2022	119.22M
September 30, 2022	120.61M
June 30, 2022	120.55M
March 31, 2022	118.11M
December 31, 2021	110.55M
September 30, 2021	65.16M
June 30, 2021	63.56M
March 31, 2021	63.12M
December 31, 2020	51.20M
September 30, 2020	60.76M
June 30, 2020	49.75M

Date	Value
March 31, 2020	27.06M
December 31, 2019	29.30M
September 30, 2019	31.07M
June 30, 2019	18.98M
March 31, 2019	12.73M
December 31, 2018	12.45M
September 30, 2018	13.76M
June 30, 2018	14.08M
March 31, 2018	12.59M
December 31, 2017	11.78M
September 30, 2017	10.42M
June 30, 2017	10.41M
March 31, 2017	8.296M
December 31, 2016	5.625M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

18.98M

Minimum

Jun 2019

120.61M

Maximum

Sep 2022

75.40M

Average

65.16M

Median

Sep 2021

Total Liabilities (Quarterly) Benchmarks

Amicus Therapeutics Inc	617.71M
Geron Corp	146.13M
Palatin Technologies Inc	24.94M
Oragenics Inc	1.798M
TG Therapeutics Inc	169.08M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly)	121.54M
Shareholders Equity (Quarterly)	35.39M
Debt to Equity Ratio	1.457
Current Ratio	3.868
Net Debt Paydown Yield	3.16%